Home › Lung Diseases › Vermont › Burlington
Lung Diseases clinical trials in Burlington, VT
4 studies for Lung Diseases are looking for participants at sites in and around Burlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
American Lung Association (ALA) Lung Health Cohort
RecruitingObservational studyHealthy volunteers welcome
- University of Vermont, Colchester · 6 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- The University of Vermont Medical Center Inc., Burlington
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RecruitingPhase 2
- University of Vermont, Colchester · 6 mi away
Deep Functional Phenotyping of the ALA Lung Health Cohort
RecruitingObservational studyHealthy volunteers welcome
- University of Vermont, Burlington
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Nashville, TN10 studies
- Dallas, TX10 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Ann Arbor, MI10 studies
Other studies in Burlington
- Heart Failure8 studies
- Acute Myeloid Leukemia7 studies
- Cancer (all types)6 studies
- COPD5 studies
- Breast Cancer5 studies
- Parkinson's Disease4 studies
- Non-Small Cell Lung Cancer4 studies
- Prostate Cancer4 studies
- Cystic Fibrosis4 studies
- Leukemia4 studies
- Cardiovascular Disease4 studies
- Metastatic Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.